Current problems in the diagnosis and treatment of functional disorders of the gastrointestinal tract
https://doi.org/10.21518/2079-701X-2015-13-112-117
Abstract
The article is devoted to the etiology, pathogenesis, clinical symptoms, approaches to diagnosis, therapy and prevention of functional dyspepsia.
About the Authors
E. M. Skvortsova
Volgograd State Medical University
Russian Federation
Russian Federation
V. V. Skvortsov
Volgograd State Medical University
Russian Federation
Russian Federation
T. A. Mukhtarov
Volgograd State Medical University
Russian Federation
Russian Federation
M. V. Potapova
Volgograd State Medical University
Russian Federation
Russian Federation
K. Y. Skvortsov
Volgograd State Medical University
Russian Federation
Russian Federation
O. F. Fedorova
Volgograd State Medical University
Russian Federation
Russian Federation
References
1. Васильев Ю.В., Яшина Н.В., Иванова Н.Г Синдром диспепсии (диагностика, лечение). Актуальные вопросы клинической медицины. М., 2001: 77-82.
2. Елагин Р.И. Лечение неязвенной диспепсии. Consilium Medicum, 2000. 2(7).
3. Ивашкин В.Т., Шептулин А.А., Лапина Т.Л., Картавенко И.М. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсии. РЖГГК, 2012. 22. 3: 80-92.
4. Amarapurkar DN, Rank P. Randomized, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J. Indian Med. Assoc., 2004. 102: 735-760.
5. Allescher HD, Bockenhoff A, Knapp G et al. Treatment of non-ulcer dyspepsia: a meta-anal-ysis of placebo-controlled prospective studies. Scand. J. Gastroenterol., 2001. 36: 934-941.
6. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut, 1999. 45 (Suppl. 2): II1II5 (September).
7. Holtmann G, Talley Nj, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N. Engl. J. Med., 2006. 354: 832-840.
8. Kanath S. Comparative evaluation of the efficacy and tol-erability of itopride and metaclopra-mide in patients with non-ulcer dyspepsia. JAMA-lndia, 2003. 2: 95-98.
9. Moayyedi P, Soo S, Deeks J et al. Systemic review: Antacids, H2-receptor antagonists, pro-kinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment. Pharmacol. Ther., 2003. 17: 1215-1227.
10. Sawant P, Das HS, Desai N et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. JAPl, 2004. 52: 626-628.
11. Материалы сайта http//www.mif-ua.com.
12. Talley NJ, Ruff K, Jiang X, et al. The Rome III classification of dyspepsia: will it help research? Dig Dis, 2008. 26: 203-09.
13. Иванов А.Н., Прянишникова А.С., Краснолобова Л.П. Современные представления о диагностике и лечении функциональной диспепсии. Фарматека, 2011. 12.
14. Губская Е.Ю. Функциональная диспепсия и Римские критерии Ill. Что нового? Национальный медицинский университет им. А.А. Богомольца. 2008.
15. Ravindra M, Kakrani AL. Clinical evaluation of itopride hydrochloride in patients with non-ulcer dyspepsia and chronic gastritis. Indian Pract, 2002. 55: 1-6.
16. Kumar RA, Venketakrishnan L, Kuruvilla A. Clinical evaluation of the efficacy and tolera-bility of itopride hydrochloride in patients with non-ulcer dyspepsia or chronic gastritis. Indian J Clin Pract, 2003. 13:-5.
17. Mam C, Mittal M. Clinical evaluation of itopride hydrochloride in patients with non-ulcer dyspepsia. Gastroenterol Today, 2003. 7: 1-4.
18. Shenoy KT, Veenasree, Leena KB. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia. J Indian Med Assoc, 2003. 101: 387-8.
19. Kamath S, Vinod K, Verghese J, Bhatia S. Comparative Evaluation of the Efficacy and Tolerability of Itopride and Metoclopramide in Patients with Non-Ulcer Dyspepsia. JAMA-lndia, 2003. 2(8): 95-8.
20. Das K. Role of Itopride in Functional Dyspepsia. Indian Pract, 2004. 57: 731-4.
21. Sawant P, Das HS, Desai H et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. J Assoc Physicians India, 2004. 52: 626-8.
22. Ganaton Post Marketing Survellance Study Group. Post Marketing Survellance Study of Ganaton (Itopride Hydrochloride) in the Management of Functional Dyspepsia. Gastroenterology Today, 2004. 8: 1-8.
23. Ganaton Postmarketing Surveillance Study Group - Postmarketing surveillance study to evaluate the efficacy and safety of ganaton (ito-pride hydrochloride) in the management of functional dyspepsia. JAMA-lndia, 2004. 3: 69-74.
24. Holtmann G, Talley NJ, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med, 2006. 354(8): 832-40.
25. Сереброва С.Ю., Журавлёва М.В., Липатова И.С., Тёмная И.С. Прокинетики сегодня: между Сциллой и Харибдой. Лечащий врач, 2014. 4.
26. Трухан Д.И., Тарасова Л.В., Гришечкина И.А. Прокинетики: в фокусе внимания итоприда гидрохлорид. Российские медицинские вести, 2013. XVIII, 3: 29-40.
27. Информационное письмо ФГБУ «НЦЭСМП» Минздрава России №1830 от 20 февраля 2015 г.
28. http//www.ema.europa.eu/ema/index. jsp?curl=pages/medicines/human/referrals/ Domperidone-containing_medicines/human_ referral_prac_000021. jsp&mid=WC0b01ac05805c516f.
29. http//www.ema.europa.eu/ema/index. jsp?curl=pages/news_and_events/ news/2013/07/news_detail_001854. jsp&mid=WC0b01ac058004d5c1.
Review
For citations:
Skvortsova EM, Skvortsov VV, Mukhtarov TA, Potapova MV, Skvortsov KY, Fedorova OF. Current problems in the diagnosis and treatment of functional disorders of the gastrointestinal tract. Meditsinskiy sovet = Medical Council. 2015;(13):112-117. (In Russ.) https://doi.org/10.21518/2079-701X-2015-13-112-117
Views:
458
Email this article 